During the COVID-19 pandemic, elderly patients with underlying condition, such as tumors,
had poor prognoses after progressing to severe pneumonia and often had poor response to …

Since the emergence of the coronavirus disease 2019 (COVID-19) pandemic, many lives
have been tragically lost to severe infections. The COVID-19 impact extends beyond the …

Pulmonary diseases across all ages threaten millions of people and have emerged as one
of the major public health issues worldwide. For diverse disease conditions, the currently …

This work presents an image‐based hybrid model incorporating the initial spatial distribution
for mesenchymal stem cell (MSC) cultivation process design. First, three levels of seeding …

Mesenchymal stromal cells (MSCs) have become one of the most investigated and applied
cells for cellular therapy and regenerative medicine. In this update of our review published in …

Acute respiratory distress syndrome (ARDS) presents as a form of acute respiratory failure
resulting from non-cardiogenic pulmonary edema due to excessive alveolocapillary …

The novel pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
causes coronavirus disease 2019 (COVID-19), a serious challenge for human health. In …

Addressing the challenges in managing ischemic tissue repair and remodelling remains a
prominent clinical concern. Current research is heavily concentrated on identifying …

Acute respiratory distress syndrome (ARDS) is the primary cause of respiratory failure in
critically ill patients. Despite remarkable therapeutic advances in recent years, ARDS …

Introduction: Coronavirus disease 2019 (COVID-19) was first reported in 2019 and has since
become a health concern due to its rapid spread and high mortality rate. With the discovery …